19 hours Ago By Defense World Staff
Charles Schwab Investment Management Inc. grew its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 7.
7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,000,664 shares of the health services provider’s stock after purchasing an additional 71,598 shares during the quarter. Charles Schwab Investment Management Inc.
owned about 1.75% of Maximus worth $74,700,000 at the end of the most recent quarter. Other institutional investors have also added to or reduced their stakes in the company.
UMB Bank n.a. raised its holdings in Maximus by 79.
8% in the 4th quarter. UMB Bank n.a.
now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares in the last quarter. Eastern Bank purchased a new stake in shares of Maximus in the 4th quarter worth about $29,000. V Square Quantitative Management LLC grew its position in shares of Maximus by 65.
9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after buying an additional 180 shares during the period. R Squared Ltd purchased a new stake in shares of Maximus in the 4th quarter worth about $54,000.
Finally, IFP Advisors Inc grew its position in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after buying an additional 302 shares during the period.
97.21% of the stock is currently owned by institutional investors. Insider Buying and Selling at MaximusIn other Maximus news, insider Ilene R.
Baylinson sold 14,500 shares of the firm’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.
00. Following the completion of the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68.
This trade represents a 85.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Also, Director Raymond B. Ruddy acquired 3,490 shares of Maximus stock in a transaction on Thursday, December 12th. The shares were purchased at an average price of $71.
46 per share, with a total value of $249,395.40. Following the completion of the purchase, the director now owns 112,520 shares in the company, valued at $8,040,679.
20. This represents a 3.20 % increase in their position.
The disclosure for this purchase can be found here. In the last ninety days, insiders bought 7,008 shares of company stock worth $497,835. 1.
60% of the stock is owned by corporate insiders. Wall Street Analyst Weigh InA number of analysts have recently weighed in on the stock. StockNews.
com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd.
Read Our Latest Research Report on MMSMaximus Stock Down 1.7 %NYSE:MMS opened at $69.98 on Tuesday.
Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.
97. The firm’s 50-day moving average price is $72.77 and its 200-day moving average price is $80.
14. The company has a market capitalization of $3.96 billion, a PE ratio of 15.
05 and a beta of 0.71. The company has a debt-to-equity ratio of 0.
82, a current ratio of 1.72 and a quick ratio of 1.72.
Maximus (NYSE:MMS – Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.
39 by $0.22. Maximus had a net margin of 5.
28% and a return on equity of 21.95%. On average, equities analysts predict that Maximus, Inc.
will post 6.15 EPS for the current fiscal year. Maximus Dividend AnnouncementThe company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th.
Shareholders of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th.
This represents a $1.20 dividend on an annualized basis and a yield of 1.71%.
Maximus’s dividend payout ratio is currently 25.81%. Maximus Company Profile (Free Report)Maximus, Inc operates as a provider of government services in the United States and internationally.
It operates through three segments: U.S. Federal Services, U.
S. Services, and Outside the U.S.
The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further ReadingFive stocks we like better than MaximusWhat is MarketRank? How to Use itHow to Protect Your Portfolio When Inflation Is RisingOptions Trading – Understanding Strike Price3 Tech Stocks Defying Sector Weakness and Thriving in 2025Insider Trading – What You Need to KnowDespite Challenges Novo Nordisk Plans to Crush GLP-1 CompetitorsWant to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
.
